Skip to main content
HOWL
NASDAQ Life Sciences

Major Investor Files Intent to Sell Additional Shares Amidst Ongoing Divestment

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.66
Mkt Cap
$31.173M
52W Low
$0.559
52W High
$2.38
52W Position info
18% above low
Off High info
72% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

HOWL sits 18% above its 52-week low of $0.559.

Summary

A key institutional investor, MPM BioVentures, has filed to sell more shares, continuing a pattern of significant divestment from Werewolf Therapeutics.


Key Events · Ownership and Investor Activity · HOWL

  • Intent to Sell Additional Shares

    MPM BioVentures 2014, L.P. has filed a Form 144 to sell 198,739 shares of common stock, valued at approximately $128,067.

  • Ongoing Institutional Divestment

    This filing follows a pattern of continuous selling by MPM BioVentures and its affiliated entities, which have sold over $2.2 million worth of shares in the past three months, indicating a sustained reduction in their stake.

  • Filer is Major Shareholder

    MPM BioVentures 2014, L.P. is identified as a significant shareholder, making its ongoing sales a notable event for the company.


Analysis · HOWL · Life Sciences

MPM BioVentures 2014, L.P., a significant institutional shareholder, has filed a Form 144 indicating its intent to sell an additional $128,067 worth of common stock. This filing comes after a period of continuous selling by MPM BioVentures and its affiliates, which have divested over $2.2 million in shares over the past three months. This sustained liquidation by a major investor suggests a lack of confidence or a strategic exit, which could exert downward pressure on the stock.

How filings like this one have moved

In the 30 days to Sep 15, 2026, 29.9% of the 1678 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.25%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HOWL was trading at $0.66 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $31.2M. The 52-week trading range was $0.56 to $2.38. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HOWL - Latest Insights

HOWL
Aug 21, 2026, 9:12 AM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $1.04
Real-time Price: $0.9403 info
Change: -$0.1012 (-10%) info
Market Cap: $46.553M info
HOWL
Aug 21, 2026, 9:10 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.04
Real-time Price: $0.9403 info
Change: -$0.1012 (-10%) info
Market Cap: $46.553M info
HOWL
Aug 21, 2026, 8:51 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.994096
Real-time Price: $0.9403 info
Change: -$0.053796 (-5%) info
Market Cap: $46.553M info
HOWL
Aug 21, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.7528
Real-time Price: $0.9403 info
Change: +$0.1875 (+25%) info
Market Cap: $46.553M info
HOWL
Aug 20, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7418
Real-time Price: $0.9403 info
Change: +$0.1985 (+27%) info
Market Cap: $46.553M info